In this paper, we measure the extent to which a biological marker is a surrogate endpoint for a clinical event by the proportional reduction in the regression coefficient for the treatment indicator due to the inclusion of the marker in the Cox regression model. We estimate this proportion by applyi
β¦ LIBER β¦
An Evaluation of a Measure of the Proportion of the Treatment Effect Explained by a Surrogate Marker
β Scribed by Paul W Bycott; Jeremy M.G Taylor
- Book ID
- 114187524
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 176 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0197-2456
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
ESTIMATING THE PROPORTION OF TREATMENT E
β
D. Y. LIN; T. R. FLEMING; V. DE GRUTTOLA
π
Article
π
1997
π
John Wiley and Sons
π
English
β 362 KB
Counterfactual Links to the Proportion o
β
Jeremy M. G. Taylor; Yue Wang; Rodolphe ThiΓ©baut
π
Article
π
2005
π
John Wiley and Sons
π
English
β 175 KB
Estimating the proportion of treatment e
β
Philippe Flandre; Yacine Saidi
π
Article
π
1999
π
John Wiley and Sons
π
English
β 56 KB
Lin, Fleming and DeGruttola (LFD) address the important problem of estimating the proportion of treatment effect (PTE) explained by a surrogate marker. Problems of interpretation of the measure as well as the theoretical basis of its formulation are well explained. This measure has been introduced t
The fragility of an altered proportion:
β
Alvan R. Feinstein
π
Article
π
1987
π
Elsevier Science
β 268 KB
An absolute measurement of the efficienc
β
T.E. Sampson; D.H. Vincent
π
Article
π
1971
π
Elsevier Science
β 556 KB
A Note on Percent Variance Explained as
β
Robert Rosenthal; Donald B. Rubin
π
Article
π
1979
π
John Wiley and Sons
π
English
β 66 KB